What is the treatment for epistaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Epistaxis

The first-line treatment for epistaxis is firm sustained compression to the lower third of the nose for 10-15 minutes, which should be attempted before proceeding to other interventions. 1

Initial Management Algorithm

  1. First-line approach:

    • Apply firm pressure to the lower third of the nose for 10-15 minutes
    • Patient should be seated leaning forward to avoid blood flowing down the throat
    • Consider applying ice packs to the nasal bridge to promote vasoconstriction
  2. If bleeding persists:

    • Apply vasoconstrictor spray such as oxymetazoline (Afrin) 2 to help constrict blood vessels, with a success rate of 65-75% 1, 3
    • Topical tranexamic acid may be particularly effective in patients on antiplatelet therapy 1 and has shown superior results compared to other topical agents in stopping bleeding within 10 minutes 4

Cauterization and Advanced Techniques

If the initial measures fail to control bleeding and a specific bleeding site can be identified:

  • Cauterization is preferred over nasal packing 1
    • Electrocautery (especially bipolar) is more effective than chemical cautery with fewer recurrences (14.5% vs 35.1%) 1, 3
    • Should be performed under local anesthesia
    • Caution: Avoid excessive or extensive cautery to prevent septal damage

Nasal Packing

For bleeding that cannot be controlled by compression, vasoconstrictors, or cauterization:

  • Options include:

    • Non-absorbable materials (petroleum jelly, BIPP gauze, PVA nasal tampons)
    • Absorbable materials (Nasopore)
    • Newer hemostatic materials (hemostatic gauzes, thrombin matrix, gelatin sponge, fibrin glue) 1, 3
  • Important considerations:

    • Monitor for complications including infection, decreased blood flow, septal perforations, pressure sores, and worsening of obstructive sleep apnea 1
    • Patients with anterior nasal packing may be discharged with appropriate antibiotics and follow-up
    • Posterior packing typically requires hospital admission for monitoring

Management of Persistent or Severe Bleeding

For intractable cases not responding to the above measures:

  • Endoscopic arterial ligation targeting the sphenopalatine artery (SPA) has a 97% success rate compared to 62% with conventional nasal packing 1, 3
  • Embolization may be considered with approximately 80% success rate but carries higher risk of serious complications including stroke (0.9-1.6%) 1

Special Considerations for Patients on Anticoagulants/Antiplatelets

  • For patients on dual antiplatelet therapy with persistent bleeding, consider temporary discontinuation of one agent (preferably clopidogrel) in consultation with the prescribing physician 1
  • Resumption of antiplatelet therapy should occur as soon as bleeding is controlled 1
  • Topical tranexamic acid has shown particular benefit in these patients 1, 5

Post-Treatment Care and Prevention

  • Nasal moisturization with saline gel or spray 1-3 times daily
  • Humidification in dry environments
  • Avoid digital trauma (nose picking) and vigorous nose blowing 1

When to Refer to Specialist or Emergency Department

  • Posterior epistaxis
  • Bleeding not controlled with anterior packing
  • Recurrent epistaxis despite treatment
  • Suspected underlying pathology requiring endoscopic evaluation 1

Warning Signs Requiring Immediate Attention

  • Return of blood from nose or mouth
  • Fever over 101°F
  • Increasing pain
  • Vision changes
  • Shortness of breath
  • Loss of color around the skin of the nose
  • Swelling of the face
  • Diffuse skin rash 1

Important note: Recent research suggests that topical tranexamic acid at a dose of 1000 mg may be more effective than 500 mg, with decreased rates of recurrent bleeding and low incidence of side effects 6. This represents a promising advancement in epistaxis management that could be incorporated into treatment protocols.

References

Guideline

Epistaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epistaxis Treatment Options: Literature Review.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023

Research

Tranexamic acid for patients with nasal haemorrhage (epistaxis).

The Cochrane database of systematic reviews, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.